Solara Active Pharma Sciences Ltd. (SOLARA): Solara Active Pharma Sciences Share Price near 52-week high after 2.56% rise
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Solara Share Price was Rs 759.80, up 2.56% from the previous close, and remained close to its 52-week high as of 21 September 2026 at 12:48 PM IST. The company’s market capitalisation stood at Rs 3,574.4 crore, placing today’s move in a clearly defined market-cap context. Solara Active Pharma Sciences Ltd. (SOLARA) is therefore in focus in Solara Share Price Today searches, Solara Stock News and Solara Share News tracking because the stock is trading near its yearly high rather than at an isolated intraday spike.
The latest Univest figures show a price of Rs 759.80 against a previous close of Rs 740.80, with the share price moving higher by Rs 19 during the morning trade window. The day’s range of Rs 734.40 to Rs 764.45 shows the stock trading in a relatively tight band around the upper end of the move. Since this is a near 52-week high event, the relevant question is not whether a record was broken, but how the price, valuation and sector context line up around the current level.
Solara Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 759.8 |
| Previous Close | Rs 740.8 |
| Today's Move | +Rs 19 (+2.56%) |
| Open | Rs 740 |
| High | Rs 764.45 |
| Low | Rs 734.4 |
| Turnover | Rs 1.6 crore |
| Market Capitalisation | Rs 3,574.4 crore |
Solara Active Pharma Sciences Ltd. (SOLARA) traded at Rs 759.8 versus the previous close of Rs 740.8, a rise of 2.56%. The stock opened at Rs 740, reached a high of Rs 764.45 and touched a low of Rs 734.4.
Solara Share Price Today reflects a move from Rs 740.80 to Rs 759.80, with the stock opening at Rs 740 and trading between Rs 734.40 and Rs 764.45 during the observed window. Turnover stood at Rs 1.6 crore. The stock is therefore trading close to its 52-week peak, with the current price sitting above the previous close by 2.56% and within reach of the day’s high of Rs 764.45.
What exactly happened today is straightforward: Solara Active Pharma Sciences traded higher than the prior session reference, stayed above its opening level and moved toward the upper end of the intraday range. The move confirms the near 52-week high event, but the available numbers do not establish a company-specific catalyst. For readers following Solara Share Price Live, this is best read as a price event first and a narrative question second.
Solara Active Pharma Sciences Ltd. (SOLARA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,574.4 crore |
| P/E Ratio | 44.49x |
| P/B Ratio | 2.81x |
| ROE | -0.63% |
| ROCE | 4.61% |
| EPS | Rs -0.34 |
| Book Value Per Share | Rs 263.29 |
| Dividend Yield | 0% |
Solara Active Pharma Sciences Ltd. (SOLARA) fundamental metrics show P/E 44.49x, P/B 2.81x, ROE -0.63%, ROCE 4.61%. These figures provide context only and are not a buy or sell signal.
Solara Active Pharma Sciences Ltd. has a market capitalisation of Rs 3574.4 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.49x, P/B at 2.81x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -0.63% and ROCE of 4.61%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -0.34, book value per share of Rs 263.29, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.32x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 44.49x |
| Benchmark Median P/E | 28.32x |
| Benchmark Average P/E | 40.61x |
| Benchmark P/E Range | 0x to 683.5x |
| Company P/B Ratio | 2.81x |
| Benchmark Median P/B | 3.08x |
| Company ROE | -0.63% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 4.61% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 3,574.4 crore |
| Benchmark Median Market Cap | Rs 677.56 crore |
Solara Active Pharma Sciences Ltd. (SOLARA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Solara Active Pharma Sciences Ltd. (SOLARA) has a P/E ratio of 44.49x, which is above the benchmark median of 28.32x, a difference of +57.1%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Solara Active Pharma Sciences Ltd. (SOLARA) has a ROE of -0.63%, which is below the benchmark median of 11.7%, a difference of -105.38%. Solara Active Pharma Sciences Ltd. (SOLARA) has a ROCE of 4.61%, which is below the benchmark median of 13.61%, a difference of -66.13%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 3,606.14 | 44.49 | 10.12 | 22.67 | 24.01 |
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,840.63 | 12.6 | 1.4 | 9.81 | 10.68 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 3,244.54 | 56.6 | 2.17 | 24.68 | 24.24 |
| Aarti Drugs Ltd. | AARTIDRUGS | 3,940.58 | 20.61 | 2.46 | 13.36 | 12.04 |
| Advanced Enzyme Technologies Ltd. | ADVENZYMES | 3,226.59 | 19.45 | 1.94 | 11.43 | 15.27 |
Solara Active Pharma Sciences Ltd. (SOLARA) has a P/E ratio of 44.49x compared with the displayed peer median of 20.61x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.63% compares with a peer median of 13.36% across the companies shown in the table. ROCE stood at 4.61% versus the displayed peer median of 15.27%, providing a capital-efficiency comparison. Solara Active Pharma Sciences Ltd. (SOLARA) has a market capitalisation of Rs 3,574.4 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Solara
- Solara Share Price traded at Rs 759.80, up 2.56% from the previous close of Rs 740.80.
- The stock stayed near its 52-week high, with the day’s high at Rs 764.45.
- Market capitalisation stood at Rs 3,574.4 crore, keeping Solara Share Price within a clearly defined size band.
- P/E was 44.49, P/B was 2.81 and EPS was -0.34, which are key Solara Fundamental Analysis inputs.
- Sector benchmarks show Solara’s ROE and ROCE below the industry medians for Pharmaceuticals & Drugs.
About Solara Active Pharma Sciences
Solara Active Pharma Sciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company name, symbol SOLARA and market classification are the core identifiers used in Solara Share Price, Solara NSE and Solara BSE tracking. The available financial records show quarterly revenue and profit figures across FY26 periods, along with book value, EPS and return ratios that are relevant for company overview pages and Solara Company News coverage.
Frequently Asked Questions
Why is Solara Share Price in the news today?
Ans. Solara Share Price is in focus because it traded at Rs 759.80, up 2.56% from the previous close, while remaining near its 52-week high. The move is verified by price data and market capitalisation of Rs 3,574.4 crore.
What is Solara Share Price today?
Ans. Solara Share Price today was Rs 759.80. It moved up Rs 19 from the previous close of Rs 740.80 and traded within a day range of Rs 734.40 to Rs 764.45 during the observed morning session.
Is Solara near its 52-week high?
Ans. Yes, Solara Share Price is trading close to its 52-week high. The day’s high of Rs 764.45 and the current price of Rs 759.80 place it near the yearly high zone without claiming a new peak.
What is Solara’s market capitalisation?
Ans. Solara Active Pharma Sciences has a market capitalisation of Rs 3,574.4 crore. That figure helps frame Solara Share Price within the wider healthcare and pharmaceuticals universe and supports comparison with listed peers.
How is Solara valued compared with the sector?
Ans. Solara Share Price sits on a P/E of 44.49 versus the industry median of 28.32 and an average of 40.61. Its P/B of 2.81 is below the sector median of 3.08.
What do Solara’s profitability ratios show?
Ans. Solara’s ROE is -0.63 and ROCE is 4.61. Both are below the same-industry medians of 11.7 and 13.61, which keeps Solara Fundamental Analysis focused on return quality rather than price alone.
What are Solara’s book value and EPS?
Ans. Solara reports book value of Rs 263.29 and EPS of -0.34. These metrics are part of standard Solara Share Price analysis and help explain the company’s valuation and earnings context.
How does Solara compare with peers?
Ans. Solara Share Price has a market cap similar to Kwality Pharmaceuticals, but its P/E of 44.49 is higher than Unichem Laboratories, Aarti Drugs and Advanced Enzyme Technologies in the latest Univest peer set.
Track Solara Share Price on Univest
Use Solara Active Pharma Sciences Ltd. (SOLARA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Solara Share Price on Univest for live share price updates, market cap, 52-week levels, valuation ratios, company financials, sector comparison and stock news coverage. Readers can use Univest to monitor Solara Share Price Today, Solara Latest News and Solara Stock Performance in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
